Helicobacter pylori infection found during upper endoscopy performed for the diagnosis of celiac, inflammatory bowel diseases, and eosinophilic esophagitis: A multicenter pediatric European study
Language English Country England, Great Britain Media print
Document type Journal Article, Multicenter Study
PubMed
38790089
DOI
10.1111/hel.13092
Knihovny.cz E-resources
- Keywords
- Helicobacter pylori, children, eradication treatment, incidental diagnosis,
- MeSH
- Celiac Disease * diagnosis epidemiology MeSH
- Child MeSH
- Eosinophilic Esophagitis * epidemiology diagnosis MeSH
- Endoscopy, Gastrointestinal MeSH
- Helicobacter pylori * isolation & purification MeSH
- Inflammatory Bowel Diseases * epidemiology diagnosis microbiology MeSH
- Helicobacter Infections * diagnosis epidemiology drug therapy MeSH
- Humans MeSH
- Adolescent MeSH
- Child, Preschool MeSH
- Prevalence MeSH
- Retrospective Studies MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Geographicals
- Europe epidemiology MeSH
BACKGROUND: Helicobacter pylori may be found during upper gastrointestinal endoscopy (UGE) performed to diagnose celiac disease (CeD), inflammatory bowel disease (IBD), and eosinophilic esophagitis (EoE). We aimed to describe the frequency of H. pylori in children undergoing UGE for CeD, IBD, and EoE and the number of children receiving eradication treatment. MATERIALS AND METHODS: A retrospective multicenter study from 14 countries included pediatric patients diagnosed with CeD, IBD, and EoE between January 2019 and December 2021. DATA COLLECTED: age, gender, hematologic parameters, endoscopic, histologic, and H. pylori culture results, and information on eradication treatment. RESULTS: H. pylori was identified in 349/3890 (9%) children [167 (48%) male, median 12 years (interquartile range 8.1-14.6)]. H. pylori was present in 10% (173/1733) CeD, 8.5% (110/1292) IBD and 7.6% (66/865) EoE patients (p = NS). The prevalence differed significantly between Europe (Eastern 5.2% (28/536), Southern 3.8% (78/2032), Western 5.6% (28/513)) and the Middle East 26.6% (215/809) [odds ratio (OR) 7.96 95% confidence interval (CI) (6.31-10.1) p < 0.0001]. Eradication treatment was prescribed in 131/349 (37.5%) patients, 34.6% CeD, 35.8% IBD, and 56.1% EoE. Predictors for recommending treatment included erosions/ulcers [OR 6.45 95% CI 3.62-11.47, p < 0.0001] and nodular gastritis [OR 2.25 95% CI 1.33-3.81, p 0.003]. Treatment rates were higher in centers with a low H. pylori prevalence (<20%) [OR 3.36 95% CI 1.47-7.66 p 0.004]. CONCLUSIONS: Identifying H. pylori incidentally during UGE performed for the most common gastrointestinal diseases varies significantly among regions but not among diseases. The indications for recommending treatment are not well defined, and less than 40% of children received treatment.
Arabkir Institute of Child and Adolescent Health Yerevan Armenia
Clinic of Children's Diseases of Vilnius University Faculty of Medicine Vilnius Lithuania
Division of Paediatric Gastroenterology and Hepatology Mitera Children's Hospital Athens Greece
Faculty of Medical sciences Department of Pediatrics University of Kragujevac Kragujevac Serbia
Faculty of Medicine Hebrew University of Jerusalem Jerusalem Israel
Faculty of Medicine in Pilsen Charles University Prague Prague Czech Republic
Faculty of Medicine Tel Aviv University Tel Aviv Israel
Paediatric Division Kaplan Medical Centre Rehovot Israel
Paediatric Gastroenterology Kaplan Medical Centre Rehovot Israel
Paediatric Gastroenterology Unit Hospital 12 de Octubre Madrid Spain
Pediatric Gastroenterology Division Wolfson Medical Center Holon Israel
Pediatric Gastroenterology Unit Puerta de Hierro Majadahonda Hospital Madrid Spain
See more in PubMed
Zamani M, Ebrahimtabar F, Zamani V, et al. Systematic review with meta‐analysis: the worldwide prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther. 2018;47(7):868‐876. doi:10.1111/apt.14561
Zabala Torrres B, Lucero Y, Lagomarcino AJ, et al. Review: prevalence and dynamics of Helicobacter pylori infection during childhood. Helicobacter. 2017;22(5). doi:10.1111/hel.12399
Kori M, Le Thi TG, Werkstetter K, et al. Helicobacter pylori infection in pediatric patients living in Europe. J Pediatr Gastroenterol Nutr. 2020;71(4):476‐483. doi:10.1097/mpg.0000000000002816
Le Thi TG, Werkstetter K, Kotilea K, et al. Management of Helicobacter pylori infection in paediatric patients in Europe: results from the EuroPedHp registry. Infection. 2022;51(4):921‐934. doi:10.1007/s15010-022-01948-y
Kalach N, Misak Z, Bontems P, et al. Systematic review and meta‐analysis of histological gastric biopsy aspects according to the updated Sydney system in children. J Pediatr Gastroenterol Nutr. 2022;74(1):13‐19. doi:10.1097/MPG.0000000000003259
Aguilera Matos I, Diaz Oliva SE, Escobedo AA, Villa Jiménez OM, Velazco Villaurrutia YDC. Helicobacter pylori infection in children. BMJ Paediatr Open. 2020;4:1‐7. doi:10.1136/bmjpo-2020-000679
Bayrak NA, Tutar E, Volkan B, et al. Helicobacter pylori infection in children with celiac disease: multi‐center, cross‐sectional study. Helicobacter. 2020;25(3):e12691. doi:10.1111/hel.12691
Wang WL, Xu XJ. Correlation between Helicobacter pylori infection and Crohn's disease: a meta‐analysis. Eur Rev Med Pharmacol Sci. 2019;23(23):10509‐10516. doi:10.26355/eurrev_201912_19691
Shah SC, Tepler A, Peek RM, et al. Association between Helicobacter pylori exposure and decreased odds of eosinophilic esophagitis—a systematic review and meta‐analysis. Clin Gastroenterol Hepatol. 2019;17(11):2185‐2198.e3.
Jones NL, Koletzko S, Goodman K, et al. Joint ESPGHAN/NASPGHAN guidelines for the management of Helicobacter pylori in children and adolescents (update 2016). J Pediatr Gastroenterol Nutr. 2017;64:991‐1003. doi:10.1097/MPG.0000000000001594
Dolstra Y, Kori M. Helicobacter pylori found incidentally during upper endoscopy performed for diagnosis of common pediatric gastrointestinal diseases. Pediatr Infect Dis J. 2023;42(10):833‐836. doi:10.1097/INF.0000000000004012
Tringali A, Thomson M, Dumonceau JM, et al. Pediatric gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) guideline executive summary. Endoscopy. 2017;49(1):83‐91. doi:10.1055/s-0042-111002
Cheng CKW, Chan J, Cembrowski GS, Assendelft OWV. Complete blood count reference interval diagrams derived from NHANES III: stratification by age, sex, and race. Lab Hematol. 2004;10(1):42‐53. doi:10.1532/LH96.04010
Iron Deficiency Anaemia Assessment, Prevention, and Control: A Guide for Programme Managers. World Health Organization; 2001. http://www.who.int/nutrition/publications/en/idaassessmentpreventioncontrol.pdf
Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)‐a metadata‐driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377‐381. doi:10.1016/j.jbi.2008.08.010
Kotilea K, Iliadis E, Nguyen J, et al. Antibiotic resistance, heteroresistance, and eradication success of Helicobacter pylori infection in children. Helicobacter. 2023;28(5):e13006. doi:10.1111/hel.13006